A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism
Clinical trial NCT04009291 · COMPLETED
Trial details
- NCT number
- NCT04009291
- Sponsor
- Ascendis Pharma A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-27
- Primary completion
- 2020-03-06
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.